Radio and PodcastRadio and PodcastLive Radio & Podcasts
What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer artwork
Science & Medicine

What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer

GRACEcast Lung Cancer Video by cancerGRACE - H. Jack West, MD

Jul 8, 201403:52Science & Medicine

"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).

Related Episodes

Continue listening to more episodes from GRACEcast Lung Cancer Video.

Management of Rare Kidney Tumors

Jul 29, 2014 - 01:55

What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for...